Skip to main content
Equibles

GSA CAPITAL PARTNERS LLP

Position in MDXH — MDxHealth SA

CIK 1362033 LONDON, X0
Back to MDXH Full portfolio

Position in MDXH

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$198,095
+$172,584 QoQ
Shares Held
481,985
+4245.3% QoQ
Ownership
0.505%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 26 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MDXH Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $16,598,580 across 18 Diagnostics & Research names. MDXH ranks #17 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NTRA
Natera, Inc.
 11,336 $3,077,157
2 TMO
Thermo Fisher Scientific Inc.
 4,702 $2,357,394
3 GH
Guardant Health, Inc.
 11,811 $1,772,004
4 BDSX
Biodesix Inc
 46,989 $1,059,601
5 DGX
Quest Diagnostics Inc
 4,971 $1,053,603
6 IDXX
Idexx Laboratories Inc /De
 1,981 $1,042,877
7 XGN
Exagen Inc.
 214,721 $998,452
8 MTD
Mettler Toledo International Inc/
 619 $790,778

All Filings in MDXH

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $198,095 481,985
2026-03-31 $25,511 11,092
2025-12-31 $253,098 70,896
2025-09-30 $47,890 10,299